Skip to main content
Clinical Trials/CTRI/2017/11/010418
CTRI/2017/11/010418CompletedPhase 4

Comparative assessment of the efficacy, safety and cost effectiveness of sertaconazole (2%) cream versus luliconazole (1%) cream in patients with dermatophytoses : A prospective, Randomized , open label, parallel study - CAESCESVLPDPROLPS

Government Medical College0 sites59 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
59

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Adults between the age group of 18 to 70 years of either gender, with clinical diagnosis and mycological confirmation (positive KOH test) for tinea corporis and tinea cruris infections, will be included in the study.
  • 2)Patient having a Physician global assessment (PGA) composite score of at least 5 will be included in the study.
  • 3)Patient willing to give written informed consent will be included in the study

Exclusion Criteria

  • 1)Patients having clinical diagnosis of tinea infections other than tinea corporis and tinea cruris,
  • 2)Patients having extensive fungal infection,
  • 3)Patients who had received topical or oral antifungal agents upto four weeks prior to the initiation of the study,
  • 4)History of hypersensitivity to study drugs,
  • 5)Immunocompromised patients,
  • 6)Patients having superadded bacterial infection,
  • 7)Pregnant or lactating women

Investigators

Similar Trials

Comparison of effect,safety and cost of... | Clinical Trial